TNIP1 and MAP1LC3A

  • Number of citations of the paper that reports this interaction (PMID 25416956)
  • 0
  • Data Source:
  • BioGRID (two hybrid)

TNIP1

MAP1LC3A

Gene Name TNFAIP3 interacting protein 1 microtubule-associated protein 1 light chain 3 alpha
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 61 interactors: ADH6 AP1M1 BYSL CCDC112 CCNG1 CDIP1 CDKN1A CFAP53 EFEMP1 EHHADH FAM161A FAM168A FUS GABARAPL1 GABARAPL2 GIT2 GTF2B GTF2H1 HDDC3 IKBKG KIFC3 MAGEB18 MAGEH1 MAP1LC3A MAP1LC3B MAPK1 MAPK10 MOB1B MOB3C MORF4L1 MORF4L2 NDC80 NFKB1 NIFK NME7 OPTN PIN1 PNKP RABAC1 RALBP1 RARA RARG RBFOX1 RNF11 RPL5 S100B SELPLG SNIP1 SUMO2 SYT6 TAX1BP1 TCEA2 TCEANC2 TNFAIP3 TNIP3 TTF2 TXLNA UBC VPS33B ZBTB25 ZNHIT1 40 interactors: AKAP13 APP ATG101 ATG13 ATG3 ATG4B ATG7 BNIP3L DVL2 EPHA7 FAM134C FUNDC1 KIF15 KXD1 MAP1A MAP1S NBR1 OPTN PIAS4 PRPF40A RABGAP1 RABGAP1L RDH12 RTKN SQSTM1 SRPK1 TBC1D1 TBC1D10A TBC1D10B TBC1D16 TBC1D17 TBC1D2 TBC1D25 TBC1D2B TBC1D5 TBC1D7 TBC1D9 TBC1D9B TNIP1 TUBA4A
Entrez ID 10318 84557
HPRD ID 09216 03144
Ensembl ID ENSG00000145901 ENSG00000101460
Uniprot IDs A4F1W8 A4F1W9 A4F1X2 A8K4N4 B7Z8K2 E7EPY1 E7ET96 Q05KP3 Q05KP4 Q15025 Q9H492
PDB IDs 3ECI
Enriched GO Terms of Interacting Partners?
Tagcloud ?
1q21  5q31  6p21  alleles  anxa6  applicable  atopic  conduct  dermatitis  direction  exclusive  histocompatibility  immunochip  influencing  loci  methodologies  mutually  opposing  overlap  overlapping  pleiotropic  prkra  psoriasis  rarely  shared  th2  traits  unreported  utilizing 
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
Tagcloud (Difference) ?
1q21  5q31  6p21  alleles  anxa6  applicable  atopic  conduct  dermatitis  direction  exclusive  histocompatibility  immunochip  influencing  loci  methodologies  mutually  opposing  overlap  overlapping  pleiotropic  prkra  psoriasis  rarely  shared  th2  traits  unreported  utilizing 
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
Tagcloud (Intersection) ?